Search clinical trials for: UK-453, 061

Total 9268 results

Pfizer

Completed

A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1

HIV-1

United Kingdom, South Africa, Australia, Canada, Italy, Poland, Switzerland, Argentina, Mexico
National Cancer Institute (NCI)

Completed

Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection

Head and Neck Cancer | Head and Neck Neoplasms

United States
St George's, University of London

Completed

Investigation of Acceptable Dose of Mobilisation and Tactile Stimulation to Enhance Upper Limb Recovery After Stroke

Stroke

United Kingdom
Patagonia Pharmaceuticals, LLC

Completed

A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis

Congenital Ichthyosis

United States
National Cancer Institute (NCI)

Completed

Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines

Prostatic Neoplasms | Prostatic Cancer

United States
St George's, University of London

Completed

Evaluation of Whether Functional Strength Training Can Enhance Motor Recovery of the Upper Limb After Stroke

Stroke

United Kingdom
St George's, University of London
The Health Foundation

Completed

Evaluation of Whether Functional Strength Training Can Enhance Recovery of Mobility After Stroke

Stroke

United Kingdom
Pfizer

Completed

Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation

Ejaculation

United States, Australia, Canada, United Kingdom
Pfizer

Completed

Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation

Ejaculation

Italy, Spain, Australia, Austria, Canada, Czech Republic, France, Germany, Israel, Norway, Poland, Sweden, Turkey, Netherlands
Pfizer
ViiV Healthcare

Completed

A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061

HIV-1

Germany
Pfizer

Completed

Assessment Of Safety Of UK-390,957

Ejaculation

Italy, United States, Australia, Austria, Canada, Czech Republic, France, Germany, Israel, Norway, Poland, Sweden, Turkey, United Kingdom
Pfizer

Terminated

Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD

Pulmonary Disease, Chronic Obstructive

Australia, Canada, Czech Republic, Croatia, Spain, Hungary, Argentina, Singapore, United Kingdom, Chile
Pfizer

Completed

A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD

Pulmonary Disease, Chronic Obstructive

Australia, United Kingdom, Argentina, Germany, India
Pfizer

Completed

Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation

Ejaculation

United States
Pfizer

Completed

Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms

Prostatic Hyperplasia

Netherlands, Czech Republic, Slovakia
Pfizer

Completed

Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction

Impotence

United States
Pfizer

Terminated

Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.

Pulmonary Disease, Chronic Obstructive

Australia, Canada, United Kingdom, Poland, Netherlands
Pfizer

Completed

Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder

Urinary Bladder, Overactive

Australia, France, Colombia, Germany, Canada, Finland, Slovakia, Spain, Switzerland, Italy, Chile, Greece, Latvia, Norway, Poland, United Kingdom
National Cancer Institute (NCI)

Completed

Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer

Neoplasms | Breast Cancer | Lung Cancer | Prostate Cancer | Colon Cancer

United States
University of British Columbia
Praxis Spinal Cord Institute; St. Paul's Hospital

Not yet recruiting

Noninvasive Neuroprosthesis for Autonomic Recovery After SCI

Spinal Cord Injuries
Pfizer

Completed

A Study In Healthy People Of Multiple Doses Of UK-396,082 Given By Mouth, To Investigate The Safety, Toleration And Time Course Of Blood Concentration Of UK-396,082 And Its Effects.

Safety | Pharmacokinetic | Phase 1 | Multiple Dose | Toleration

Belgium
Radboud University Medical Center
Canisius-Wilhelmina Hospital; Johnson & Johnson Medical BV, The Netherlands

Completed

Functional Evaluation of a Standard and a High-flexion Knee Prosthesis Using Thigh-calf Contact Force Measurements

Arthroplasty, Replacement, Knee

Netherlands
University College, London

Completed

Trialling an Online UK Dementia Awareness for Caregivers Course (DAC-UK)

Dementia | Caregiver Burden

United Kingdom
Liverpool John Moores University
University of Illinois at Chicago; Georgia Southern University

Completed

Effect of Probiotics on Endurance Athletes' Microbiome at Rest and Post-race

Probiotics | Athletes | Gut Microbiota | Aerobic Exercise | Gut Microbiome | Gastrointestinal Tract Irritation

United Kingdom
University of Texas Southwestern Medical Center

Withdrawn

Simulated Radiotherapy Treatment Assisted With Pediatric Radiation Oncology With Movie Induced Sedation Effect Technique

Childhood Cancer
University of Hull
Hull University Teaching Hospitals NHS Trust

Unknown

Hull Early Walking Aids for Transtibial Amputees - Randomised Control Trial (HEART) (HEART)

Unilateral Trans-tibial Amputees

United Kingdom
Sunnybrook Health Sciences Centre

Completed

Assessment of Left-sided Cardiac Sparing Through the Use of 3-dimensional Surface Matching-based Deep Inspiration Breath Hold and Active Breathing Control

Left-Sided Breast Cancer

Canada
Imperial College Healthcare NHS Trust

Completed

Comparison of Tesio and LifeCath Twin Permanent Dialysis Catheters (VyTes)

Hemodialysis

United Kingdom
NS Pharma, Inc.
Cooperative International Neuromuscular Research Group; Nippon Shinyaku Co.... and other collaborators

Completed

Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

United States, Canada
National Center of Neurology and Psychiatry, Japan
Nippon Shinyaku Co., Ltd.

Completed

Exploratory Study of NS-065/NCNP-01 in DMD

Duchenne Muscular Dystrophy

Japan
University of Minnesota
National Institutes of Health (NIH); National Center for Research Resources... and other collaborators

Completed

Repetitive Transcranial Magnetic Stimulation for the Treatment of Focal Hand Dystonia

Dystonia, Focal, Task-specific

United States
Centre Hospitalier Universitaire de Saint Etienne
Association pour le Développement de la Recherche sur l'Appareil Locomoteur...

Completed

Effects of Whole Body Vibration (WBV) on Musculoskeletal System of Aged Women (VIBROS)

Osteopenia

France
NS Pharma, Inc.
Nippon Shinyaku Co., Ltd.

Completed

Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys With DMD (Galactic53)

Duchenne Muscular Dystrophy

Spain, United States, Russian Federation, Italy, China, Turkey
NS Pharma, Inc.
Nippon Shinyaku Co., Ltd.

Active, not recruiting

Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)

Duchenne Muscular Dystrophy

Korea, Republic of, Chile, Japan, China, United Kingdom, Netherlands, Spain, Norway, Russian Federation, Australia, Greece, Italy, New Zealand, Turkey, Mexico, Czechia, Canada
NS Pharma, Inc.
Cooperative International Neuromuscular Research Group; Nippon Shinyaku Co.... and other collaborators

Completed

Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

United States, Canada
NS Pharma, Inc.

Approved for marketing

The Expanded Access Use of Viltolarsen in Duchenne Muscular Dystrophy With Confirmed Exon 53 Amenable Mutation

Muscular Dystrophy, Duchenne | DMD
University Hospital Muenster

Completed

Pharyngeal Electrical Stimulation for the Treatment of Post-extubation Dysphagia in Acute Stroke

Stroke | Dysphagia

Germany
St Mark's Hospital Foundation

Completed

Transabdominal Electrical Stimulation for Constipation

Constipation
Centre d'Investigation Clinique et Technologique...
Adep Assistance

Completed

Effect of Non Invasive Brain Stimulation on Experimentally Induced Dyspnea (Breathlessness) (tDCS-Dyspnea)

Dyspnea

France
Jeppe Lange, MD

Completed

Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture

Dupuytrens Contracture

Denmark
South Eastern Health and Social Care Trust

Unknown

Negative Pressure Wound Therapy in Groin Dissection

Neoplasm Metastasis | Skin Neoplasms | Secondary Malignant Neoplasm of Lymph Node | Non-healing Surgical Wound (Disorder)

United Kingdom
Kukje Pharma

Completed

[KSR-001-P01]Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristic of KSR-001

Dry Eye Syndromes

Korea, Republic of
Medical Expeditions Ltd
Bangor University; Science in Sport; Plans Branch of Headquarters Army Recruiting...

Completed

MEDEX Hidden Valley 2008

Hypoxia

United Kingdom
NS Pharma, Inc.
Nippon Shinyaku Co., Ltd.

Completed

Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53)

Duchenne Muscular Dystrophy

Korea, Republic of, Chile, Taiwan, China, United States, United Kingdom, Netherlands, Spain, Australia, Norway, Russian Federation, Greece, Italy, Turkey, Mexico, Canada, Hong Kong, New Zealand, Ukraine
Taipei Veterans General Hospital, Taiwan

Unknown

Bihemispheric Modulation of the Motor Cortex by Transcranial Direct Current Stimulation in Subacute Stroke Patients

Stroke

Taiwan
Reprogenetics
McGill University; Yale University; Reprogenetics Lationoamerica S.A.C, Lima,... and other collaborators

Terminated

Preimplantation Genetic Diagnosis (PGD) by Array Comparative Genome Hybridization (CGH) and Blastocyst Biopsy

Infertility | Miscarriage

Peru
Vertex Pharmaceuticals Incorporated

Enrolling by invitation

Evaluation of Long-Term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor in Cystic Fibrosis Participants 1 Year of Age and Older

Cystic Fibrosis

United States, Australia, Germany, Sweden, Switzerland, France, Netherlands, United Kingdom
Vertex Pharmaceuticals Incorporated

Enrolling by invitation

A Study of Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA) in Healthy Adult Panelists

Cystic Fibrosis

United States
Vertex Pharmaceuticals Incorporated

Recruiting

A Study To Evaluate the Relative Bioavailability, Food Effect, and Dose Proportionality of a Granule Formulation of Vanzacaftor/Tezacaftor/Deutivacaftor(VNZ/TEZ/D-IVA)

Cystic Fibrosis

United States
Xinhua Hospital, Shanghai Jiao Tong University...

Unknown

Effect of rTMS on the Abnormal Executive Function of ASD Children

Executive Dysfunction | ASD

China

Search clinical trials for: UK-453, 061

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations